Product

M-CENK

Aliases

M-CENK, Suspension for Infusion, Cryopreserved (M-CENK) (Cohort 2 part B)

Name

M-ceNK

1 clinical trial

1 indication

1 poster

Indication

Metastatic Solid Tumor

Clinical trial

Phase 1 Open-Label Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors

Status: Recruiting, Estimated PCD: 2024-06-21

Poster

Characterization of the anti-tumor activity of memory cytokine enriched NK cells (M-ceNK) against tumors with neuroendocrine features